SCHEMBL9324119

SCHEMBL9324119

Fc1ccc(/C=N/[C@@H]2C3CCN(CC3)[C@H]2C(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 14/20 0.52
ACHE P22303 2/20 0.44
BACE1 P56817 2/20 0.44
BCHE P06276 1/20 0.43
MRGPRX1 Q96LB2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9324143 1.00 TACR1 (0.52) TACR1ACHEBACE1BCHEMRGPRX1
SCHEMBL9324127 1.00 TACR1 (0.52) TACR1ACHEBACE1BCHEMRGPRX1
SCHEMBL9324137 1.00 TACR1 (0.52) TACR1ACHEBACE1BCHEMRGPRX1
SCHEMBL9323089 0.89 TACR1 (0.54) TACR1
SCHEMBL9323097 0.89 TACR1 (0.54) TACR1
SCHEMBL9323102 0.89 TACR1 (0.54) TACR1
SCHEMBL9323107 0.89 TACR1 (0.54) TACR1
SCHEMBL9325219 0.88 TACR1 (0.52) TACR1ACHEBACE1BCHE
SCHEMBL9322742 0.88 TACR1 (0.52) TACR1ACHEBACE1BCHE
SCHEMBL9325229 0.88 TACR1 (0.52) TACR1ACHEBACE1BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0409931-B1 QUINUCLIDINE THERAPEUTIC AGENTS PFIZER (US) 1994-02-16 EP disclosed
US-5162339-A Substance P Antagonists, Gastrointestinal and Central Nervous System Disorders, Antiinflammatory Agents, Analgesics PFIZER INC. (US) 1992-11-10 US disclosed
WO-1990005525-A1 QUINUCLIDINE DERIVATIVES AS SUBSTANCE P ANTAGONISTS PFIZER INC. (US) 1990-05-31 WO disclosed